Overview

Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL

Status:
Completed

Trial end date:
2017-11-30

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy, safety, and tolerability of oral naltrexone used in conjunction with buprenorphine in adults with Opioid Use Disorder transitioning from buprenorphine maintenance prior to the first dose of VIVITROL.

Phase:

Phase 3

Details

Lead Sponsor:

Alkermes, Inc.

Treatments:

Analgesics, Opioid
Buprenorphine
Naltrexone